Optimal Amikacin Levels for Patients with Sepsis in Intensive Care Unit of Cipto Mangunkusumo Hospital, Jakarta, Indonesia

Show other versions (1)

Background: Amikacin is one of the antibiotics of choice for sepsis and septic shock. Pharmacokinetic of amikacin can be influenced by septic condition with subsequent effect on its pharmacodynamic. At Cipto Mangunkusumo Hospital (RSCM), Jakarta, adult patients in the ICU were given standard amikaci...

Full description

Bibliographic Details
Published in:	Acta Medica Indonesiana
Main Authors:	Gestina Aliska, Rianto Setiabudi, purwantyastuti purwantyastuti, Anis Karuniawati, Rudyanto Sedono, Trisni U Dewi, Muhammad K Azwar
Format:	Article
Language:	English
Published:	Interna Publishing 2017-11-01
Subjects:	amikacin aminoglycoside sepsis ICU MIC
Online Access:	https://actamedindones.org/index.php/ijim/article/view/179

Similar Items

Optimal Amikacin Levels for Patients with Sepsis in Intensive Care Unit of Cipto Mangunkusumo Hospital, Jakarta, Indonesia
by: Gestina Aliska, et al.
Published: (2017-11-01)

Glomerular Filtration Rate Changes in Neonates with Sepsis Treated with Amikacin and Cefotaxime
by: Fatemeh-Sadat Tabatabaei, et al.
Published: (2022-01-01)

Amikacin: Area Under Curve for Once Daily Dose and Its Correlation with Plasma Concentration at Six Hours Post Infusion
by: Teera Kolladaruengkri, et al.
Published: (2003-03-01)

Time-dependent pharmacodynamics of amikacin on Mycobacterium abscessus growth and resistance emergence
by: Joy E. Gibson, et al.
Published: (2024-02-01)

Evaluation of Intra-Articular Amikacin Administration in an Equine Non-inflammatory Joint Model to Identify Effective Bactericidal Concentrations While Minimizing Cytotoxicity
by: Lynn Pezzanite, et al.
Published: (2021-05-01)

Challenges in achieving the guideline-recommended amikacin level for Mycobacterium avium complex pulmonary disease
by: Takuya Akutsu, et al.
Published: (2025-05-01)

Amikacin use in critically ill patients requiring renal replacement therapy: the AMIDIAL-ICU study
by: Vincent Dupont, et al.
Published: (2025-03-01)

Development of a Predictive Dosing Nomogram to Achieve PK/PD Targets of Amikacin Initial Dose in Critically Ill Patients: A Non-Parametric Approach
by: Anne Coste, et al.
Published: (2023-01-01)

Initial In Vivo Evaluation of a Novel Amikacin-Deoxycholate Hydrophobic Salt Delivers New Insights on Amikacin Partition in Blood and Tissues
by: Styliani Xiroudaki, et al.
Published: (2021-01-01)

The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults
by: Khan O, et al.
Published: (2020-06-01)

Aminoglycoside-induced hearing deficits – a review of cochlear ototoxicity
by: Lucretia Petersen, et al.
Published: (2015-04-01)

A Novel Mouse Model of Aminoglycoside-Induced Hyperacusis and Tinnitus
by: Ryan J. Longenecker, et al.
Published: (2020-09-01)

Comparative Study between Combined Intravenous and Nebulized Amikacin versus Intravenous Amikacin Alone for Treatment of Ventilator Associated Pneumonia
by: Sameh Seyam, et al.
Published: (2022-06-01)

Intrathecal use of amikacin: a case report
by: L. Barrou, et al.

Comparison of clinical outcomes of treatment with cefepime monotherapy vs. amikacin-ceftriaxone combination in children with chemotherapy-induced fever and neutropenia
by: Zahra Ghelichkhan, et al.
Published: (2025-04-01)

Aminoglycoside 6′-<i>N</i>-acetyltransferase Type Ib [AAC(6′)-Ib]-Mediated Aminoglycoside Resistance: Phenotypic Conversion to Susceptibility by Silver Ions
by: Craig M. Reeves, et al.
Published: (2020-12-01)

Multidrug-Resistant Bacteria Colonization in Patients Admitted to Dr. Cipto Mangunkusumo Hospital Jakarta, Indonesia
by: Selvi Nafisa Shahab, et al.
Published: (2024-07-01)

Multidrug-Resistant Bacteria Colonization in Patients Admitted to Dr. Cipto Mangunkusumo Hospital Jakarta, Indonesia
by: Selvi Nafisa Shahab, et al.
Published: (2024-04-01)

Efficacy and safety of intravitreal injection of amikacin for endophthalmitis: a systematic review
by: ZiChao Ji, et al.
Published: (2023-07-01)

Amikacin-loaded selenium nanoparticles improved antibacterial and antibiofilm activity of amikacin against bovine mastitis-causing Staphylococcus aureus
by: Leila Asadpour, et al.
Published: (2025-01-01)

The Direction of the Antibacterial Effect of Rutin Hydrate and Amikacin
by: Maria Miklasińska-Majdanik, et al.
Published: (2023-09-01)

Effect of mannitol on the pharmacokinetics of amikacin in wistar rats
by: Hugo Juárez Olguín, et al.
Published: (2009-08-01)

Review on Population Pharmacokinetics of Amikacin in Paediatrics
by: Keerthana Chandrasekar, et al.
Published: (2022-12-01)

Carvacrol attenuates amikacin-induced nephrotoxicity in the rats
by: Cemil Çolak, et al.
Published: (2024-08-01)

A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)
by: Dalia M. El Fawy, et al.
Published: (2020-10-01)

Factors Associated with Mortality of Intensive Care Unit Patients with Acute Kidney Injury at Cipto Mangunkusumo National Central General Hospital
by: Aida Lydia, et al.
Published: (2020-02-01)

Factors Associated with Mortality of Intensive Care Unit Patients with Acute Kidney Injury at Cipto Mangunkusumo National Central General Hospital
by: Aida Lydia, et al.
Published: (2020-02-01)

Pharmacokinetics of Intraperitoneal Vancomycin and Amikacin in Automated Peritoneal Dialysis Patients With Peritonitis
by: Pâmela Falbo dos Reis, et al.
Published: (2021-05-01)

Comparative analysis of the pathogenicity between multidrug-resistant Acinetobacter baumannii clinical isolates: isolation of highly pathogenic multidrug-resistant A. baumannii and experimental therapeutics with fourth-generation cephalosporin cefozopran
by: Nishida S, et al.
Published: (2018-10-01)

Probing amikacin interaction with albumin: A combined multispectral and molecular docking investigation
by: Fatemeh Javaheri-Ghezeldizaj, et al.
Published: (2024-10-01)

Protective Effect of Pentoxifylline on Amikacin-Induced Renal Toxicity in Mice
by: Mohammad Shokati Sayad, et al.
Published: (2023-10-01)

Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages
by: Jimin Zhang, et al.
Published: (2018-05-01)

Protective role of Punica granatum juice in inhibit nephrotoxicity Induced by amikacin in albino Rabbits
by: Hazim I. Ahmad, et al.
Published: (2023-02-01)

Therapeutic Drug Monitoring of Amikacin in Neutropenic Oncology Patients
by: Maria Aquino, et al.
Published: (2023-02-01)

Population Pharmacokinetic Characteristics of Amikacin in Suspected Cases of Neonatal Sepsis in a Low-Resource African Setting: A Prospective Nonrandomized Single-Site Study
by: Seth K. Amponsah, PhD, et al.
Published: (2017-01-01)

The comparative effects of erythromycin and amikacin on acute respiratory Pseudomonas aeruginosa infection
by: Mohsen Yazdanian, et al.
Published: (2023-03-01)

Protective role of Pomegranate (punica granatam L.) juice in inhibition liver toxicity induced by amikacin in white Newzealad Rabbits
by: Dakheel Hussein Hadree
Published: (2023-02-01)

Plasma concentration and eGFR in preterm and term neonates receiving gentamicin or successive amikacin therapy
by: Bonifasius Siyuka Singu, et al.
Published: (2023-01-01)

Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada
by: Maria Luisa Aznar, et al.
Published: (2019-06-01)

Characteristics of Mediastinal Tumor Patients in Cipto Mangunkusumo National Hospital Jakarta
by: Zulkifli Amin
Published: (2013-06-01)